Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | MS-275 | GDSC1000 | pan-cancer | AAC | 0.026 | 0.7 |
mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.023 | 0.7 |
mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
mRNA | 968 | CTRPv2 | pan-cancer | AAC | 0.036 | 0.7 |
mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | Sunitinib | FIMM | pan-cancer | AAC | -0.083 | 0.7 |
mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | -0.025 | 0.7 |
mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
mRNA | Doxorubicin | FIMM | pan-cancer | AAC | 0.069 | 0.7 |